TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 48 filers reported holding TELA BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,136 | -45.4% | 7,892 | -30.9% | 0.00% | – |
| Q2 2023 | $115,613 | -24.7% | 11,413 | -20.9% | 0.00% | – |
| Q1 2023 | $153,609 | +186.8% | 14,437 | +210.0% | 0.00% | – |
| Q4 2022 | $53,556 | – | 4,657 | +38708.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 12 | -94.2% | 0.00% | – |
| Q1 2022 | $2,000 | – | 206 | +488.6% | 0.00% | – |
| Q4 2021 | $0 | – | 35 | +6.1% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 33 | -99.5% | 0.00% | – |
| Q2 2021 | $109,000 | +3533.3% | 6,781 | +3256.9% | 0.00% | – |
| Q1 2021 | $3,000 | -96.2% | 202 | -96.1% | 0.00% | – |
| Q4 2020 | $78,000 | -27.8% | 5,162 | -21.1% | 0.00% | – |
| Q3 2020 | $108,000 | +260.0% | 6,544 | +182.4% | 0.00% | – |
| Q2 2020 | $30,000 | +1400.0% | 2,317 | +865.4% | 0.00% | – |
| Q1 2020 | $2,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,565,709 | $24,996,000 | 10.33% |
| Opaleye Management Inc. | 1,643,367 | $11,520,000 | 5.19% |
| INDUSTRY VENTURES, L.L.C. | 579,745 | $4,064,000 | 4.31% |
| Velan Capital Investment Management LP | 498,238 | $3,493,000 | 3.54% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 116,095 | $825,000 | 0.83% |
| HAMILTON LANE ADVISORS LLC | 264,366 | $1,853,000 | 0.72% |
| AIGH Capital Management LLC | 306,464 | $2,156,000 | 0.57% |
| Worth Venture Partners, LLC | 113,012 | $904,000 | 0.53% |
| Granite Point Capital Management, L.P. | 227,644 | $1,596,000 | 0.41% |
| Orbimed Advisors | 3,027,542 | $21,223,000 | 0.38% |